arrow
J

Jens Wuerfel

F. Hoffmann-La Roche AG
H指数:58
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial

Ponesimod作为添加治疗在活动性复发多发性硬化患者中的应用(POINT):一项III期、随机、安慰剂对照临床试验

2025-07-130
PRE
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis
2024-12-240
PRE
Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation

与心房颤动患者的明显和隐蔽卒中相关的生物标志物,影像学和临床因素

STROKE
IF8.9
2023-10-013
OAAI
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients

一项多中心纵向MRI研究,评估leman-pv软件在多发性硬化症患者白质病变检测中的准确性

2023-01-287
OA
Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation

三甲胺-N-氧化物与心房颤动患者的心血管死亡率和血管性脑损伤相关

HEART
IF4.4
2023-01-0215
OA
Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis

顺磁性rims是多发性硬化症中有前途的诊断成像生物标志物

2022-08-2635
OAAI
Renal Function and Body Mass Index Contribute to Serum Neurofilament Light Chain Levels in Elderly Patients With Atrial Fibrillation
2022-04-1427
OAAI
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
2021-06-2222
OAAI
Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis
BRAIN
IF11.7
2021-05-10103
OAAI